Publication of the New 13th edition of Diagnosis and Management of Type 2 Diabetes by Drs. Steven Edelman and Robert Henry
03-01-2017
PCI is pleased to announce the publication of the new 13th edition of Diagnosis and Management of Type 2 Diabetes by Drs. Steven Edelman and Robert Henry. The handbook has been extensively updated and reorganized since the publication of the last edition in 2013 and includes the results of the EMPA-REG and LEADER CV outcome trials as well as the numerous new anti-diabetic meds approved in the last 4 years. The new edition is now in 4-color and is the best yet!
Diagnosis and Management of Type 2 Diabetes 13E provides a practical, concise guide to the management of type 2 diabetes. All available oral and injectable anti-diabetic agents are reviewed in the book with separate chapters for each class of oral agents, insulin therapy, and glucoregulatory hormones. Key clinical trial data on each of the available agents is presented in detail along with current prescribing guidelines and CV safety and benefit trial data. The book contains a treatment algorithm for initial treatment of type 2 diabetes. Nonpharmacologic measures, treatment of micro- and macro-vascular complications, and a review of the diabetes prevention trials are also presented in the book.
Steven V. Edelman, MD and Robert R. Henry, MD, are Professors of Medicine in the Division of Endocrinology, Diabetes and Metabolism at the UCSD and VA Medical Centers in San Diego. Dr. Edelman is also the Founder and Director of the Taking Control of Your Diabetes organization. Dr. Henry was a past president of the American Diabetes Association.
2017 • 528 pages • ISBN: 978-1-943236-00-8 • $34.95